BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 8347619)

  • 1. Real-time measurements of kinetics of EGF binding to soluble EGF receptor monomers and dimers support the dimerization model for receptor activation.
    Zhou M; Felder S; Rubinstein M; Hurwitz DR; Ullrich A; Lax I; Schlessinger J
    Biochemistry; 1993 Aug; 32(32):8193-8. PubMed ID: 8347619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand-binding enhances the affinity of dimerization of the extracellular domain of the epidermal growth factor receptor.
    Odaka M; Kohda D; Lax I; Schlessinger J; Inagaki F
    J Biochem; 1997 Jul; 122(1):116-21. PubMed ID: 9276679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two EGF molecules contribute additively to stabilization of the EGFR dimer.
    Lemmon MA; Bu Z; Ladbury JE; Zhou M; Pinchasi D; Lax I; Engelman DM; Schlessinger J
    EMBO J; 1997 Jan; 16(2):281-94. PubMed ID: 9029149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stoichiometry, kinetic and binding analysis of the interaction between epidermal growth factor (EGF) and the extracellular domain of the EGF receptor.
    Domagala T; Konstantopoulos N; Smyth F; Jorissen RN; Fabri L; Geleick D; Lax I; Schlessinger J; Sawyer W; Howlett GJ; Burgess AW; Nice EC
    Growth Factors; 2000; 18(1):11-29. PubMed ID: 10831070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGF induces increased ligand binding affinity and dimerization of soluble epidermal growth factor (EGF) receptor extracellular domain.
    Hurwitz DR; Emanuel SL; Nathan MH; Sarver N; Ullrich A; Felder S; Lax I; Schlessinger J
    J Biol Chem; 1991 Nov; 266(32):22035-43. PubMed ID: 1657987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The extracellular domain of the epidermal growth factor receptor. Studies on the affinity and stoichiometry of binding, receptor dimerization and a binding-domain mutant.
    Brown PM; Debanne MT; Grothe S; Bergsma D; Caron M; Kay C; O'Connor-McCourt MD
    Eur J Biochem; 1994 Oct; 225(1):223-33. PubMed ID: 7925442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization.
    Ferguson KM; Berger MB; Mendrola JM; Cho HS; Leahy DJ; Lemmon MA
    Mol Cell; 2003 Feb; 11(2):507-17. PubMed ID: 12620237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 40-kDa epidermal growth factor/transforming growth factor alpha-binding domain produced by limited proteolysis of the extracellular domain of the epidermal growth factor receptor.
    Kohda D; Odaka M; Lax I; Kawasaki H; Suzuki K; Ullrich A; Schlessinger J; Inagaki F
    J Biol Chem; 1993 Jan; 268(3):1976-81. PubMed ID: 8420971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor (EGF) induces oligomerization of soluble, extracellular, ligand-binding domain of EGF receptor. A low resolution projection structure of the ligand-binding domain.
    Lax I; Mitra AK; Ravera C; Hurwitz DR; Rubinstein M; Ullrich A; Stroud RM; Schlessinger J
    J Biol Chem; 1991 Jul; 266(21):13828-33. PubMed ID: 1856216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stabilization of an active dimeric form of the epidermal growth factor receptor by introduction of an inter-receptor disulfide bond.
    Sorokin A; Lemmon MA; Ullrich A; Schlessinger J
    J Biol Chem; 1994 Apr; 269(13):9752-9. PubMed ID: 8144568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism of the epidermal growth factor receptor extracellular ligand binding domain: the dimer interface depends on domain stabilization.
    Zhang Z; Wriggers W
    Biochemistry; 2011 Mar; 50(12):2144-56. PubMed ID: 21275429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A variant epidermal growth factor receptor exhibits altered type alpha transforming growth factor binding and transmembrane signaling.
    Moriai T; Kobrin MS; Hope C; Speck L; Korc M
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):10217-21. PubMed ID: 7937865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the N-oligosaccharides attached to the atypical Asn-X-Cys sequence of recombinant human epidermal growth factor receptor.
    Sato C; Kim JH; Abe Y; Saito K; Yokoyama S; Kohda D
    J Biochem; 2000 Jan; 127(1):65-72. PubMed ID: 10731668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of epidermal growth factor receptor autophosphorylation and high-affinity binding.
    Böni-Schnetzler M; Pilch PF
    Proc Natl Acad Sci U S A; 1987 Nov; 84(22):7832-6. PubMed ID: 3500470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a determinant of epidermal growth factor receptor ligand-binding specificity using a truncated, high-affinity form of the ectodomain.
    Elleman TC; Domagala T; McKern NM; Nerrie M; Lönnqvist B; Adams TE; Lewis J; Lovrecz GO; Hoyne PA; Richards KM; Howlett GJ; Rothacker J; Jorissen RN; Lou M; Garrett TP; Burgess AW; Nice EC; Ward CW
    Biochemistry; 2001 Jul; 40(30):8930-9. PubMed ID: 11467954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of the effect of ErbB2 on epidermal growth factor receptor binding and dimerization.
    Li Y; Macdonald-Obermann J; Westfall C; Piwnica-Worms D; Pike LJ
    J Biol Chem; 2012 Sep; 287(37):31116-25. PubMed ID: 22822073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surfactant protein D suppresses lung cancer progression by downregulation of epidermal growth factor signaling.
    Hasegawa Y; Takahashi M; Ariki S; Asakawa D; Tajiri M; Wada Y; Yamaguchi Y; Nishitani C; Takamiya R; Saito A; Uehara Y; Hashimoto J; Kurimura Y; Takahashi H; Kuroki Y
    Oncogene; 2015 Feb; 34(7):838-45. PubMed ID: 24608429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding specificities and affinities of egf domains for ErbB receptors.
    Jones JT; Akita RW; Sliwkowski MX
    FEBS Lett; 1999 Mar; 447(2-3):227-31. PubMed ID: 10214951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different epidermal growth factor (EGF) receptor ligands show distinct kinetics and biased or partial agonism for homodimer and heterodimer formation.
    Macdonald-Obermann JL; Pike LJ
    J Biol Chem; 2014 Sep; 289(38):26178-26188. PubMed ID: 25086039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gefitinib induces epidermal growth factor receptor dimers which alters the interaction characteristics with ¹²⁵I-EGF.
    Björkelund H; Gedda L; Barta P; Malmqvist M; Andersson K
    PLoS One; 2011; 6(9):e24739. PubMed ID: 21931838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.